Incubation period: Evidences on SARS-CoV-2 (COVID-19) |

                                Profession
                                
Mobile
                                        
                                Speciality
                                
                                Medical Council
                                
                                Registration Number

Editorial

Incubation period: Evidences on SARS-CoV-2 (COVID-19)

Dr KK Aggarwal, 04 April 2020
5062 Views

#Multispeciality

We present to you a series of daily questions related to various aspects of COVID-19, which summarizes what is known and what additional information is needed.Incubation Period (Part 4)How long after the infection do symptoms appear? Are people infectious during this time?What do we know?The best estimate of the incubation period of COVID-19 at present stands at 5.1 days, with 99% of individuals exhibiting symptoms within 14 days following exposure.1Less than 2.5% of infected individuals exhibit symptoms sooner than 2 days following exposure. 1The range of incubation periods is wide, with estimates of 24,2 3, 3 and 18 days.4COVID-19 test can be positive in individuals lacking clinical symptoms.2,5-8Individuals can be infectious while they are asymptomatic.7-10 Additionally, asymptomatic individuals can carry similar amounts of virus in their nose and throat as s...

To Read or comment on this article,

create a free account.

Create Account

Already registered?

Comments

Earn 5 points for every comment you post

Dr Ramesh Bijlani

Do those who are positive for infection but remain asymptomatic throughout develop immunity to the infection?

REPLY

06 April - 15:32hrs | View Replies()
Dr Imtiyaz Doctor

People suffering from rheumatoid arthritis taking hcqs regularly, r they immune to covid 19?is there any study done?

REPLY

04 April - 21:11hrs | View Replies()
Dr Vinod Ohri

Excellent information

REPLY

04 April - 11:03hrs | View Replies()
Dr MOHAN SHARMA

Informative. Cleared many doubts. Thak you Sir.

REPLY

04 April - 10:47hrs | View Replies()
Dr Anand Kamat

Thank you sir. Very big peroid has to be given say 20 to 25 days for saying that a person is NOT tranasmitting disease

REPLY

04 April - 10:38hrs | View Replies()
Dr Hemant Tadwalkar

Very informative and authentic article, clears most of the doubts for us as well as to answer the queries of patients. Thanks Sir

REPLY

04 April - 09:31hrs | View Replies()
Dr RAJESHDATT MEHTA

Useful update

REPLY

04 April - 09:11hrs | View Replies()
Dr Prakash Rabadiya

True

REPLY

04 April - 08:36hrs | View Replies()
Dr T Kalaiselvan

daily updates most useful

REPLY

04 April - 07:10hrs | View Replies()
Dr Deepak Ranade

Very relevant topic.

REPLY

04 April - 05:50hrs | View Replies()
Dr Madhavan Ranganathan

Dengue was even more dangerous a few yrs back and PCT was the only diagnostic criterion till the RDT came and NS1 antigen tests came into widespread use and the treatment was standardized making it a less fearsome disease.Will the same happen to Vivid,as it happened to H1N1

REPLY

04 April - 05:50hrs | View Replies()
Dr Sahil Khot

Good Information 👌👌👌🙏🙏🙏

REPLY

03 April - 16:53hrs | View Replies()

Recommended CME's

Good Pharmacy Practices:Certification Course Modules

Pharmacists

A comprehensive course on dengue-screening, diagnosis and management

Infectious Diseases

Management of Fungal Infections

Dermatology

Allergic Rhinitis: Approach to Day to Day Management

Allergy & Clinical Immumology

NUTRITIONAL STRATEGY IN DIABETES MANAGEMENT DURING COVID-19

Diabetes & Endocrinology

Topical Antibiotic in the Management of Skin and Soft Tissue Infection

Dermatology

Trending Articles

Editorial

Incubation period: Evidences on SARS-CoV-2 (COVID-19)

Dr KK Aggarwal, 04 April 2020
#Multispeciality

We present to you a series of daily questions related to various aspects of COVID-19, which summarizes what is known and what additional information is needed.

Incubation Period (Part 4)

How long after the infection do symptoms appear? Are people infectious during this time?

What do we know?

The best estimate of the incubation period of COVID-19 at present stands at 5.1 days, with 99% of individuals exhibiting symptoms within 14 days following exposure.¹Less than 2.5% of infected individuals exhibit symptoms sooner than 2 days following exposure.¹
The range of incubation periods is wide, with estimates of 24,²3,³ and 18 days.⁴
COVID-19 test can be positive in individuals lacking clinical symptoms.^2,5-8
Individuals can be infectious while they are asymptomatic.^7-10Additionally, asymptomatic individuals can carry similar amounts of virus in their nose and throat as symptomatic individuals.¹¹
While the infectious period is largely unknown, it could possibly be up to 10-14 days.^12-14
Approximately 4¹⁵to 7.5⁴days are there, on an average, between symptom onset in successive cases of a single transmission chain.
A majority of individuals is admitted to the hospital within 8-14 days of symptom onset.¹⁶
Patients are positive for COVID-19 via PCR for 8-37 days following symptom onset.¹⁶
Individuals may test positive via PCR for 5-13 days after symptoms disappear and hospital discharge.¹⁷The ability of these individuals to infect others is not clearly known.
As per WHO, no evidence of re-infection with SARS-CoV-2 after recovery exists.¹⁸
Experimentally infected macaques could not be reinfected after their primary infection resolved.¹⁹

What do we need to know?

The average infectious period during which individuals can transmit the disease?
Are individuals infectious after hospital discharge and clinical recovery, or do positive PCR tests only detect non-infectious virus?
Can individuals become re-infected after recovery? If yes, how long after?

References

Lauer SA, Grantz KH, Bi Q, Jones FK, Zheng Q, Meredith HR, et al. The Incubation Period of Coronavirus Disease 2019 (COVID-19) From Publicly Reported Confirmed Cases: Estimation and Application. Annals of Internal Medicine 2020.
Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, et al. Clinical characteristics of 2019 novel coronavirus infection in China. medRxiv 2020, 2020.02.06.20020974.
Backer JA, Klinkenberg D, Wallinga J. The incubation period of 2019-nCoV infections among travellers from Wuhan, China. medRxiv 2020, 2020.01.27.20018986.
Li Q, Guan X, Wu P, Wang X, Zhou L, Tong Y, et al. Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus–Infected Pneumonia. New England Journal of Medicine 2020.
Bai Y, Yao L, Wei T, Tian F, Jin DY, Chen L, Wang M. Presumed Asymptomatic Carrier Transmission of COVID-19. JAMA.
Chan JFW, Yuan S, Kok KH, to KKW, Chu H, Yang J, et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. The Lancet 2020.
The Novel Coronavirus Pneumonia Emergency Response Epidemiology, T., The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19) — China, 2020. China CDC Weekly 2020, 2, 1-10.
Zhen-Dong T, An T, Ke-Feng L, Peng L, Hong-Ling W, Jing-Ping Y, et al. Potential Presymptomatic Transmission of SARS-CoV-2, Zhejiang Province, China, 2020. Emerging Infectious Disease journal 2020, 26 (5).
CDC, Situation summary. https://www.cdc.gov/coronavirus/2019-nCoV/summary.html.
Rothe C, Schunk M, Sothmann P, Bretzel G, Froeschl G, Wallrauch C, et al. Transmission of 2019-nCoV Infection from an Asymptomatic Contact in Germany. New England Journal of Medicine 2020.
Zou L, Ruan F, Huang M, Liang L, Huang H, Hong Z, et al. SARS-CoV-2 Viral Load in Upper Respiratory Specimens of Infected Patients. New England Journal of Medicine 2020.
[Wuhan Pneumonia] The Hospital Authority stated that 2 critically ill patients needed external life support treatment. https://www.singtao.ca/4037242/2020-01-14/news-%E3%80%90%E6%AD%A6%E6%BC%A2%E8%82%BA%E7%82%8E%E3%80%91%E9%86%AB%E7%AE%A1%E5%B1%80%E6%8C%872%E5%90%8D%E9%87%8D%E7%97%87%E7%97%85%E6%82%A3%E9%9C%80%E9%AB%94%E5%A4%96%E7%94%9F%E5%91%BD%E6%94%AF%E6%8C%81%E6%B2%BB%E7%99%82/?variant=zh-hk.
Li R, Pei S, Chen B, Song Y, Zhang T, Yang W, et al. Substantial undocumented infection facilitates the rapid dissemination of novel coronavirus (SARS-CoV2). Science 2020, eabb3221.
Security, J. C. f. H., 2019-nCoV resources and updates on the emerging novel coronavirus. 2020.
Du Z, Xu X, Wu Y, Wang L, Cowling BJ, Meyers LA. The serial interval of COVID-19 from publicly reported confirmed cases. medRxiv 2020, 2020.02.19.20025452.
Zhou F, Yu T, Du R, Gan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. The Lancet.
Lan L, Xu D, Ye G, Xia C, Wang S, Li Y, et al. Positive RT-PCR Test Results in Patients Recovered From COVID-19. Jama 2020.
Lau S. Coronavirus: WHO official says there’s no evidence of ‘reinfected’ patients in China https://www.scmp.com/news/china/society/article/307404/coronavirus-who-official-says-theres-no-evidence-reinfected.
Bao L, Deng W, Gao H, Xiao C, Liu J, Xue J, et al. Reinfection could not occur in SARS-CoV-2 infected rhesus macaques. bioRxiv 2020, 2020.03.13.990226.

(Source: DHS Science and Technology, Master Question List for COVID-19 (caused by SARS-CoV-2), Weekly Report, 18 March 2020)

(To be continued)

Dr KK Aggarwal

President CMAAO, HCFI and Past National President IMA

Instance ID Token

Needs Permission

Coronavirus Live Count Map India

COVID-19 Vaccine Updates

Coronavirus Protocols

To Read or comment on this article,

create a free account.

Comments

Good Pharmacy Practices:Certification Course Modules

A comprehensive course on dengue-screening, diagnosis and management

Management of Fungal Infections

Allergic Rhinitis: Approach to Day to Day Management

NUTRITIONAL STRATEGY IN DIABETES MANAGEMENT DURING COVID-19

Topical Antibiotic in the Management of Skin and Soft Tissue Infection

Good Pharmacy Practices:Certification Course Modules

A comprehensive course on dengue-screening, diagnosis and management

Management of Fungal Infections

Allergic Rhinitis: Approach to Day to Day Management

NUTRITIONAL STRATEGY IN DIABETES MANAGEMENT DURING COVID-19

Topical Antibiotic in the Management of Skin and Soft Tissue Infection

Recommendations

Trending Articles

eMediNexus

Give us your email address and we'll send our best articles.

Instance ID Token

Needs Permission

Update Your Profile

LOGIN

SIGN UP

SEARCH

Coronavirus Live Count Map India

COVID-19 Vaccine Updates

Coronavirus Protocols

Email This

To Read or comment on this article,

create a free account.

Comments

Good Pharmacy Practices:Certification Course Modules

A comprehensive course on dengue-screening, diagnosis and management

Management of Fungal Infections

Allergic Rhinitis: Approach to Day to Day Management

NUTRITIONAL STRATEGY IN DIABETES MANAGEMENT DURING COVID-19

Topical Antibiotic in the Management of Skin and Soft Tissue Infection

Good Pharmacy Practices:Certification Course Modules

A comprehensive course on dengue-screening, diagnosis and management

Management of Fungal Infections

Allergic Rhinitis: Approach to Day to Day Management

NUTRITIONAL STRATEGY IN DIABETES MANAGEMENT DURING COVID-19

Topical Antibiotic in the Management of Skin and Soft Tissue Infection

Recommendations

Trending Articles

eMediNexus

Give us your email address and we'll send our best articles.